![Mustang Bio Inc](/common/images/company/N_MBIO.png)
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for ... Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.14 | -4.77815699659 | 2.93 | 3.04 | 2.4 | 204600 | 2.83250367 | CS |
4 | -2.98 | -51.6464471404 | 5.77 | 6.7 | 2.4 | 418404 | 4.10331209 | CS |
12 | 2.5821 | 1241.99134199 | 0.2079 | 6.7 | 0.1066 | 8620199 | 0.27365469 | CS |
26 | 2.46 | 745.454545455 | 0.33 | 6.7 | 0.1066 | 4713411 | 0.27672617 | CS |
52 | 1.48 | 112.977099237 | 1.31 | 6.7 | 0.1066 | 9888215 | 0.58135326 | CS |
156 | -11.9205 | -81.033955338 | 14.7105 | 17.55 | 0.1066 | 3553806 | 1.26557422 | CS |
260 | -54.06 | -95.092348285 | 56.85 | 78.3 | 0.1066 | 2739280 | 12.15426631 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales